Accelerate Diagnostics, Inc. (AXDX) Reaches $22.55 After 4.00% Up Move; Wellington Management Group Llp Has Trimmed Norwegian Cruise Line Hldgs (NCLH) Holding By $20.64 Million

June 14, 2018 - By Michael Collier

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Logo

The stock of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) is a huge mover today! The stock increased 3.20% or $0.7 during the last trading session, reaching $22.55. About 148,511 shares traded. Accelerate Diagnostics, Inc. (NASDAQ:AXDX) has declined 29.70% since June 14, 2017 and is downtrending. It has underperformed by 42.27% the S&P500. Some Historical AXDX News: ; 23/03/2018 – Accelerate Diagnostics, Inc. Announces Pricing of $150 Million Convertible Notes Offering; 09/05/2018 – ACCELERATE DIAGNOSTICS 1Q LOSS/SHR 37C, EST. LOSS/SHR 32C; 24/04/2018 – Accelerate Diagnostics Forms Golden Cross: Technicals; 22/03/2018 Accelerate Diagnostics Inc. Announces $150 Million Convertible Notes Offering; 23/03/2018 – ACCELERATE DIAGNOSTICS- AN ENTITY AFFILIATED WITH ONE OF ACCELERATE DIAGNOSTICS’S DIRECTORS HAS AGREED TO PURCHASE AN AGGREGATE OF $30 MLN OF NOTES; 30/04/2018 – Accelerate Diagnostics to Review First Quarter 2018 Results on May 9th; 09/05/2018 – ACCELERATE DIAGNOSTICS 1Q CASH & CASH EQUIVALENTS $126.8M; 26/04/2018 – FDA: Accelerate Diagnostics Inc- Accelerate PhenoTest BC kit, Ref #10101018. The firm name on the label is Accelerate; 22/03/2018 – Accelerate Diagnostics Inc. Announces $150M Convertible Notes Offering; 19/04/2018 – FBO:Veteran Aff: Veterans Affairs Contract Award – 65–Accelerate Diagnostics, Inc (65VII) 65VII Diagnostic, Reagents, Test KitThe move comes after 6 months positive chart setup for the $1.22 billion company. It was reported on Jun, 14 by Barchart.com. We have $23.45 PT which if reached, will make NASDAQ:AXDX worth $48.68M more.

Wellington Management Group Llp decreased Norwegian Cruise Line Hldgs (NCLH) stake by 6.93% reported in 2018Q1 SEC filing. Wellington Management Group Llp sold 396,928 shares as Norwegian Cruise Line Hldgs (NCLH)’s stock declined 6.59%. The Wellington Management Group Llp holds 5.33 million shares with $282.20 million value, down from 5.72M last quarter. Norwegian Cruise Line Hldgs now has $12.30 billion valuation. The stock increased 2.41% or $1.29 during the last trading session, reaching $54.73. About 1.29 million shares traded. Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH) has risen 6.81% since June 14, 2017 and is uptrending. It has underperformed by 5.76% the S&P500. Some Historical NCLH News: ; 02/05/2018 – Norwegian Cruise Line Raises 2018 View To Adj EPS $4.55-Adj EPS $4.70; 22/03/2018 – Norwegian Cruise Access Event Set By SunTrust for Mar. 29; 02/05/2018 – Norwegian Cruise Line Load Factor and Pricing Continuing to Be Well Ahead of Prior Yr for the Remaining Quarters of 2018 and Throughout 2019; 14/05/2018 – Morgan Stanley Intl Adds Norwegian Cruise, Cuts Cigna: 13F; 18/04/2018 – Norwegian Cruise Closes Above 50-Day Moving Average: Technicals; 02/05/2018 – NORWEGIAN CRUISE 1Q REV. $1.3B, EST. $1.29B; 20/04/2018 – Consolidated Research: 2018 Summary Expectations for Norwegian Cruise Line, Integrated Device Technology, Align Technology, Lou; 15/03/2018 – NORWEGIAN CRUISE LINE HOLDINGS LTD – ON MARCH 15, FRANK J. DEL RIO, PRESIDENT, CEO OF CO ESTABLISHED PREARRANGED TRADING PLAN – SEC FILING; 02/05/2018 – Norwegian Cruise Line Sees 2Q Adjusted EPS “Appoximately $1.02”; 07/03/2018 Norwegian Cruise Line Holdings Ltd. Announces New Terminal at PortMiami

Analysts await Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) to report earnings on August, 14. They expect $1.03 earnings per share, up 13.19% or $0.12 from last year’s $0.91 per share. NCLH’s profit will be $231.43M for 13.28 P/E if the $1.03 EPS becomes a reality. After $0.60 actual earnings per share reported by Norwegian Cruise Line Holdings Ltd. for the previous quarter, Wall Street now forecasts 71.67% EPS growth.

Among 22 analysts covering Norwegian Cruise Line (NASDAQ:NCLH), 16 have Buy rating, 1 Sell and 5 Hold. Therefore 73% are positive. Norwegian Cruise Line had 60 analyst reports since August 5, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, May 7 by Tigress Financial. Macquarie Research downgraded Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) on Thursday, November 30 to “Underperform” rating. The stock of Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) earned “Equal-Weight” rating by Morgan Stanley on Friday, November 10. The rating was upgraded by Goldman Sachs to “Neutral” on Wednesday, February 24. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, October 19. Zacks downgraded the shares of NCLH in report on Monday, August 10 to “Buy” rating. The stock has “Buy” rating by UBS on Friday, August 12. The firm has “Buy” rating given on Thursday, March 17 by SunTrust. On Friday, February 2 the stock rating was maintained by Morgan Stanley with “Equal-Weight”. SunTrust maintained the shares of NCLH in report on Thursday, November 16 with “Hold” rating.

Wellington Management Group Llp increased Shiloh Inds Inc (NASDAQ:SHLO) stake by 81,700 shares to 1.05M valued at $9.13 million in 2018Q1. It also upped Carmax Inc (NYSE:KMX) stake by 176,656 shares and now owns 4.49M shares. Thor Inds Inc (NYSE:THO) was raised too.

Since March 2, 2018, it had 0 insider buys, and 2 selling transactions for $1.09 billion activity. On Friday, March 2 the insider Apollo Management Holdings GP – LLC sold $546.00 million.

Investors sentiment increased to 1.67 in Q1 2018. Its up 0.33, from 1.34 in 2017Q4. It is positive, as 38 investors sold NCLH shares while 91 reduced holdings. 61 funds opened positions while 154 raised stakes. 208.22 million shares or 2.74% more from 202.66 million shares in 2017Q4 were reported. Capital Guardian Trust reported 521,240 shares or 0.39% of all its holdings. Gradient Investments Ltd Liability invested in 0.03% or 9,903 shares. Axa reported 13,657 shares. Caisse De Depot Et Placement Du Quebec holds 22,490 shares. Advisory Ntwk Limited Liability Com holds 146 shares or 0% of its portfolio. Retirement Of Alabama holds 98,496 shares. Driehaus Capital Mngmt Ltd Com holds 10,936 shares or 0.02% of its portfolio. Kansas-based Creative Planning has invested 0.02% in Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH). Comerica Bankshares, Michigan-based fund reported 68,922 shares. Aviance Mgmt Ltd Com has invested 0.01% in Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH). Gam Holdg Ag owns 8,681 shares. Cwm Limited Liability Corp reported 261 shares stake. C M Bidwell Assocs Limited stated it has 0.37% of its portfolio in Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH). Korea Inv accumulated 158,449 shares. Public Employees Retirement Association Of Colorado stated it has 33,274 shares.

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States. The company has market cap of $1.22 billion. It offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast. It currently has negative earnings. The firm was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012.

Investors sentiment increased to 1.1 in 2018 Q1. Its up 0.29, from 0.81 in 2017Q4. It increased, as 10 investors sold Accelerate Diagnostics, Inc. shares while 29 reduced holdings. 14 funds opened positions while 29 raised stakes. 20.31 million shares or 2.07% more from 19.90 million shares in 2017Q4 were reported. Goldman Sachs Group Inc Inc accumulated 82,085 shares. Deutsche Bank Ag stated it has 0% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Gilder Gagnon Howe & Co Ltd Liability has 86,532 shares. Parametric Portfolio Ltd Liability holds 30,644 shares. Thompson Investment Management holds 0.12% or 28,200 shares. Morgan Stanley holds 0% or 278,490 shares in its portfolio. The Manitoba – Canada-based Great West Life Assurance Can has invested 0% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). The New York-based Citigroup Inc has invested 0% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Axa invested 0.03% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Marshall Wace Llp invested 0.01% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). D E Shaw & holds 0% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) or 59,984 shares. Quantbot Techs Limited Partnership stated it has 557 shares or 0% of all its holdings. Swiss Retail Bank reported 0% stake. Next Century Growth Invsts Ltd Limited Liability Company holds 1.62% or 531,737 shares. Lord Abbett And Com Ltd Liability has invested 0% in Accelerate Diagnostics, Inc. (NASDAQ:AXDX).

More news for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) were recently published by: Seekingalpha.com, which released: “Premarket analyst action – healthcare” on May 24, 2018. Seekingalpha.com‘s article titled: “Stocks To Watch: Focus On E3, IHopb And The World Cup” and published on June 09, 2018 is yet another important article.

Analysts await Accelerate Diagnostics, Inc. (NASDAQ:AXDX) to report earnings on August, 2. They expect $-0.37 EPS, down 19.35% or $0.06 from last year’s $-0.31 per share. After $-0.37 actual EPS reported by Accelerate Diagnostics, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Among 5 analysts covering Accelerate Diagnostics (NASDAQ:AXDX), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Accelerate Diagnostics had 10 analyst reports since August 25, 2015 according to SRatingsIntel. The stock of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) has “Buy” rating given on Sunday, September 17 by Piper Jaffray. The firm earned “Neutral” rating on Tuesday, August 25 by BTIG Research. As per Wednesday, December 13, the company rating was downgraded by BTIG Research. Piper Jaffray maintained it with “Buy” rating and $3200 target in Thursday, August 3 report. BTIG Research reinitiated it with “Buy” rating and $3400 target in Wednesday, July 12 report. The rating was initiated by Piper Jaffray on Wednesday, December 16 with “Overweight”. JP Morgan maintained Accelerate Diagnostics, Inc. (NASDAQ:AXDX) rating on Tuesday, August 9. JP Morgan has “Overweight” rating and $25 target. The rating was initiated by William Blair with “Outperform” on Friday, January 8. The stock of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) has “Overweight” rating given on Thursday, March 24 by JP Morgan.

Since February 20, 2018, it had 7 buys, and 0 sales for $4.73 million activity. The insider SCHULER JACK W bought 15,000 shares worth $377,250.

Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>